Tag: biosimilars

How to Use the FDA Orange Book and Purple Book for Drug Safety Information
28 Jan, 2026

How to Use the FDA Orange Book and Purple Book for Drug Safety Information

by Trevor Ockley | Jan, 28 2026 | Health | 15 Comments

Learn how to use the FDA Orange Book and Purple Book to verify drug safety, spot withdrawn medications, and check biosimilar equivalence. Essential for pharmacists, clinicians, and patients.

Continue Reading
When Can Biosimilars Be Automatically Substituted? U.S. Rules Explained
18 Jan, 2026

When Can Biosimilars Be Automatically Substituted? U.S. Rules Explained

by Trevor Ockley | Jan, 18 2026 | Health | 10 Comments

In the U.S., only certain biosimilars are designated as interchangeable by the FDA, allowing pharmacists to swap them for brand-name biologics without a doctor’s approval. Learn how it works, which ones qualify, and why state laws make it complicated.

Continue Reading